Suppr超能文献

格雷夫斯病循环中Tγ/δ淋巴细胞亚群的系列分析

Serial analysis of circulating T gamma/delta lymphocyte subpopulations in Graves' disease.

作者信息

Sasián S, Rojano J, Gavilán I, Aguilar M, Escobar L, Girón J A

机构信息

Service of Internal Medicin, Hospital Universitario Puerta del Mar, Facultad de Medicina, Cádiz, Spain.

出版信息

Endocr Res. 1998 May;24(2):285-95. doi: 10.1080/07435809809135535.

Abstract

In the present paper the distribution of peripheral blood T gamma/delta lymphocytes in Graves' disease patients is analyzed in order to correlate them with disease activity and with prognosis. Eighteen patients with Graves' disease, 24 patients with Hashimoto's thyroiditis and 32 sex- and age-matched healthy control subjects were studied. Peripheral blood CD3+ alpha/beta and gamma/delta T lymphocytes as well as CD4+ and CD8+ T cells, and CD19 (B) lymphocytes were analyzed by cytofluorometry. At diagnosis, patients who required a radical treatment for thyrotoxicosis control showed a significant decrease of T gamma/delta lymphocytes and an increase of B cells when compared with those who maintained the euthyroid state after methimazole. No correlation was detected between the percentages of these subpopulations and serum free thyroxine. This decreased proportion did not normalize after methimazole or radical treatments. These results suggest that the cytotoxic T gamma/delta compartment of the immune system is altered in patients with Graves' disease.

摘要

在本论文中,对格雷夫斯病患者外周血Tγ/δ淋巴细胞的分布进行了分析,以便将它们与疾病活动和预后相关联。研究了18例格雷夫斯病患者、24例桥本甲状腺炎患者以及32名性别和年龄匹配的健康对照者。通过细胞荧光测定法分析外周血CD3⁺α/β和γ/δT淋巴细胞以及CD4⁺和CD8⁺T细胞,还有CD19(B)淋巴细胞。在诊断时,与那些在服用甲巯咪唑后维持甲状腺功能正常状态的患者相比,需要进行根治性治疗以控制甲状腺毒症的患者表现出Tγ/δ淋巴细胞显著减少以及B细胞增加。这些亚群的百分比与血清游离甲状腺素之间未检测到相关性。在服用甲巯咪唑或进行根治性治疗后,这种降低的比例并未恢复正常。这些结果表明,格雷夫斯病患者免疫系统的细胞毒性Tγ/δ区室发生了改变。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验